On October 8, 2026 IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, reported that Stacy Lindborg, Ph.D., President and Chief Executive Officer, will participate in the following October 2026 investor conferences.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Maxim Growth Summit 2026
Date: October 12 – 14, 2026
Location: Hard Rock Hotel, New York, NY
Presentation: Oncology Panel, October 14, 2026, at 9:00 a.m. ET
For more information and a complete agenda of the Maxim Growth Summit, please visit View Source
2026 ThinkEquity Conference
Date: October 15, 2026
Location: Mandarin Oriental Hotel, New York, NY
Presentation: 1:30 p.m. ET in the Boardroom
For more information and a complete agenda of the ThinkEquity Conference, please visit View Source
The Company will host 1×1 meetings throughout the conferences. For more information or to schedule a meeting, please contact Maxim Group or ThinkEquity conference representatives or email [email protected].
(Press release, IMUNON, OCT 8, 2026, View Source [SID1234673285])